ATE178583T1 - Kardiovaskulär aktive 2-amino-1,2,3,4- tetrahydronaphthalene - Google Patents

Kardiovaskulär aktive 2-amino-1,2,3,4- tetrahydronaphthalene

Info

Publication number
ATE178583T1
ATE178583T1 AT95932664T AT95932664T ATE178583T1 AT E178583 T1 ATE178583 T1 AT E178583T1 AT 95932664 T AT95932664 T AT 95932664T AT 95932664 T AT95932664 T AT 95932664T AT E178583 T1 ATE178583 T1 AT E178583T1
Authority
AT
Austria
Prior art keywords
hydrogen atoms
groups
formula
tetrahydronaphthalenes
amino
Prior art date
Application number
AT95932664T
Other languages
English (en)
Inventor
Stefania Montanari
Daniela Botta
Paolo Cavalleri
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE178583T1 publication Critical patent/ATE178583T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95932664T 1994-09-13 1995-09-05 Kardiovaskulär aktive 2-amino-1,2,3,4- tetrahydronaphthalene ATE178583T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941869A IT1271008B (it) 1994-09-13 1994-09-13 Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare

Publications (1)

Publication Number Publication Date
ATE178583T1 true ATE178583T1 (de) 1999-04-15

Family

ID=11369549

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932664T ATE178583T1 (de) 1994-09-13 1995-09-05 Kardiovaskulär aktive 2-amino-1,2,3,4- tetrahydronaphthalene

Country Status (7)

Country Link
EP (1) EP0781268B1 (de)
JP (1) JPH10505096A (de)
AT (1) ATE178583T1 (de)
AU (1) AU3563395A (de)
DE (1) DE69508947T2 (de)
IT (1) IT1271008B (de)
WO (1) WO1996008463A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116209433A (zh) * 2020-08-20 2023-06-02 俄勒冈健康科学大学 小分子白蛋白结合剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072061B1 (de) * 1981-08-05 1985-05-15 FISONS plc Aminderivate, Verfahren zu deren Produktion und diese enthaltende pharmazeutische Zusammensetzungen
IT1254521B (it) * 1992-03-17 1995-09-25 Zambon Spa Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
IT1271411B (it) * 1993-09-14 1997-05-28 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare

Also Published As

Publication number Publication date
DE69508947T2 (de) 1999-12-02
ITMI941869A1 (it) 1996-03-13
WO1996008463A1 (en) 1996-03-21
IT1271008B (it) 1997-05-26
DE69508947D1 (de) 1999-05-12
JPH10505096A (ja) 1998-05-19
EP0781268A1 (de) 1997-07-02
EP0781268B1 (de) 1999-04-07
ITMI941869A0 (it) 1994-09-13
AU3563395A (en) 1996-03-29

Similar Documents

Publication Publication Date Title
ES2126068T3 (es) Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene.
AU7667498A (en) Anti-inflammatory tyrosine derivatives
RU94036774A (ru) Ингибирование пролиферации клеток гладкой мускулатуры и рестеноза
DE69326231D1 (de) Cholesterinspiegelsenkendes mittel
CO4410181A1 (es) Derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol
GB0018272D0 (en) Chemical compounds IV
NO905591D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminopyrimidin-karboksamider.
FI971039A (fi) Sydän-verisuonijärjestelmään aktiivisesti vaikuttavat 2-amino-1,2,3,4-tetrahydronaftaleenijohdannaiset
FI892344A (fi) 6-fenyl-3-piperazinylalkyl-1h,3h -pyrimidin-2-4-dionderivat, deras framstaellning och deras terapeutiska anvaendning.
OA09930A (fr) Quinoléines 2-substituées pour le traitement des leishmanioses
KR930003908A (ko) 염증, 국소빈혈-유도된 세포의 손상 및 근디스트로피의 치료방법
DE69408580D1 (de) 2-amino-1,2,3,4-tetrahydronaphthalenderivate mit cardiovaskulärer wirkung
ATE52080T1 (de) Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen.
ATE178583T1 (de) Kardiovaskulär aktive 2-amino-1,2,3,4- tetrahydronaphthalene
ES8101584A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina
ES2152278T3 (es) Compuestos de ciclopentadienilmagnesio puenteados y procesos para su preparacion y su aplicacion para la preparacion de metalocenos.
AU8058391A (en) Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same
GR81827B (de)
DE3268541D1 (en) Benzodioxane-imidazoline compounds, their preparation and use
TW356467B (en) Oxazoloquinolinone derivatives their preparation and their therapeutic application
AU1498299A (en) 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
DK0970042T3 (da) 5-hydroxymethyl-2-aminotetraliner som kardiovaskulære midler
SE9603284D0 (sv) New compounds
GR3002594T3 (en) Aromatic thioethers
DE69905144D1 (de) N,N'-Diacylthiocystine